id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1994-P-0012-0003,FDA,FDA-1994-P-0012,"Director, Division of OTC Drug Products, Center for Drug Evaluation & Research (HFD-560)",Other,LET-Letter,1997-03-25T05:00:00Z,1997,3,,,2008-05-16T23:18:51Z,,0,0,09000064804fc780
FDA-1994-P-0012-0004,FDA,FDA-1994-P-0012,"Director, Division of OTC Drug Products, Center for Drug Evaluation & Research (HFD-560)",Other,LET-Letter,1997-03-25T05:00:00Z,1997,3,,,2008-05-16T23:18:51Z,,0,0,09000064804fc781
FDA-1994-P-0012-0002,FDA,FDA-1994-P-0012,"Director, Division of OTC Drug Products, Center for Drug Evaluation & Research (HFD-560)",Other,LET-Letter,1997-03-25T05:00:00Z,1997,3,,,2008-05-16T23:18:51Z,,0,0,09000064804fc77f
FDA-1994-P-0012-0001,FDA,FDA-1994-P-0012,"Director, Division of OTC Drug Products, Center for Drug Evaluation & Research (HFD-560)",Other,LET-Letter,1997-03-25T05:00:00Z,1997,3,,,2008-05-16T23:18:51Z,,0,0,09000064804fc736